- Current report filing (8-K)
January 07 2009 - 3:43PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF
1934
Date of report (Date of earliest
event reported)
|
January 7,
2009
|
|
NEW YORK HEALTH CARE,
INC.
(Exact Name of Registrant as Specified
in Its Charter)
New York
|
|
1-12451
|
|
11-2636089
|
(State or Other
Jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
Incorporation
|
|
File
Number)
|
|
Identification
No.)
|
|
1850 McDonald Avenue, Brooklyn,
New York
|
11223
|
|
(Address of Principal Executive
Offices)
|
(Zip
Code)
|
(212)
679-7778
(Registrant's Telephone Number,
Including Area Code)
(Former Name or Former Address, if
Changed Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction
A.2. below):
o
|
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
INFORMATION TO BE INCLUDED IN THE
REPORT
Section 8 - Other
Events
Item 8.01 Other
Events
New York Health Care, Inc. (the
“Company
”
) has filed a Form 15
today
with the Securities and Exchange
Commission (
“
SEC
”
) to voluntarily deregister its common
stock. The Company is eligible to deregister because it has fewer than 300
holders of record of its common stock. In filing the Fo
rm 15, the Company's
obligations
to file certain
reports and forms with the SEC, including Forms 10-K, 10-Q and 8-K,
are
immediately suspended. The Company
expects that deregistration of its common stock will become effective within 90
days.
The Company is deregistering because it
believes that the incremental cost of compliance with the Sarbanes-Oxley Act of
2002 and other public company reporting requirements does not provide a
discernable benefit to the Company and is not in the best interest
s
of its shareholders. Factors
influencing the Company's decision include
the following
:
– The high
accounting, legal and administrative
costs of preparing and
filing periodic reports and other filings with the SEC in comparison to the size
of the Company.
– The
need for senior management
of the Company to devote more time to the business of the Company
.
– The
need to maintain the confidentiality of sensitive business information that
would otherwise require SEC disclosure.
– The
already
limited trading in the Company's common
stock.
.
–
The fact that current trading prices of
the common stock make it unlikely that the Company could
e
ffectively use its common stock to
compensate employees, raise capital or make
acquisitions.
As a result of deregistering with the
SEC, the Company's common stock will cease to be eligible to trade on the
Over-the-Counter Bulletin Board. The Company's securities will continue to be
traded over the counter on the Pink Sheets, but the Company can make no
assurance that any broker will continue to make a market in the Company's common
stock.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.
|
NEW
YORK HEALTH CARE, INC.
|
|
(Registrant)
|
|
|
|
Date: January 7,
2009
|
By:
|
/s/ Murry
Englard
|
|
Murry Englard, Chief Executive
Officer
|
New York Health Care (CE) (USOTC:BBAL)
Historical Stock Chart
From Oct 2024 to Nov 2024
New York Health Care (CE) (USOTC:BBAL)
Historical Stock Chart
From Nov 2023 to Nov 2024